TAK – Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company L

TAK

$21.18

Name : Takeda Pharmaceutical Company L

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $67,668,254,720.00

EPSttm : 0.07

Takeda Pharmaceutical Company L

$21.18

1.63%

$0.34

TAK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.1

Margin Of Safety %

Put/Call OI Ratio

0.35

EPS Next Q Diff

EPS Last/This Y

148.97

EPS This/Next Y

49.96

Price

20.86

Target Price

21.26

Analyst Recom

Performance Q

19.95

Upside

-89.9%

Beta

Ticker: TAK

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	TAK	18.54	0.11	0.00	4398
2026-10-14	TAK	19.02	0.11	0.00	4390
2026-10-15	TAK	19.45	0.11	0.73	4482
2026-10-16	TAK	19.69	0.23	0.00	4913
2026-10-19	TAK	19.61	0.63	0.05	2227
2026-10-20	TAK	20.09	0.52	0.23	2561
2026-10-21	TAK	19.94	0.52	0.00	2587
2026-10-22	TAK	20.38	0.52	0.14	2593
2026-10-23	TAK	20.25	0.51	0.04	2600
2026-10-26	TAK	20.43	0.38	0.34	3172
2026-10-27	TAK	20.28	0.37	0.17	3241
2026-10-28	TAK	20.15	0.37	0.02	3243
2026-10-29	TAK	20.04	0.35	2.71	3382
2026-10-30	TAK	20.92	0.34	0.08	3628
2026-11-02	TAK	20.88	0.34	0.07	3596
2026-11-03	TAK	20.75	0.34	0.08	3583
2026-11-04	TAK	21.07	0.35	0.09	3576
2026-11-05	TAK	21.21	0.35	0.00	3559
2026-11-06	TAK	21.02	0.35	0.00	3504
2026-11-09	TAK	21.09	0.36	0.00	3479
2026-11-10	TAK	20.91	0.36	0.00	3479
2026-11-11	TAK	20.85	0.35	0.00	3505
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	TAK	18.56	-	3009.6	149.59
2026-10-14	TAK	19.03	-	3052.4	154.63
2026-10-15	TAK	19.46	-	3067.6	154.63
2026-10-16	TAK	19.69	-	3021.8	154.63
2026-10-19	TAK	19.61	-	2998.0	154.63
2026-10-20	TAK	19.61	-	2998.0	154.63
2026-10-21	TAK	20.08	-	3047.6	154.63
2026-10-22	TAK	20.38	-	3039.5	154.63
2026-10-23	TAK	20.25	-	2982.1	154.63
2026-10-26	TAK	20.44	-	3021.6	154.63
2026-10-27	TAK	20.28	-	3016.1	148.67
2026-10-28	TAK	20.15	-	3012.7	148.67
2026-10-29	TAK	20.04	-	3020.2	148.67
2026-10-30	TAK	20.92	-	2407.7	148.67
2026-11-02	TAK	20.88	-	2317.7	148.67
2026-11-04	TAK	21.07	-	2356.3	148.67
2026-11-05	TAK	21.21	-	2335.7	148.67
2026-11-06	TAK	21.01	-	2293.2	148.67
2026-11-09	TAK	21.10	-	2321.9	148.67
2026-11-10	TAK	20.91	-	2310.0	148.67
2026-11-11	TAK	20.86	-	2310.0	148.67
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	TAK	0	0.07	0.09
2026-10-14	TAK	0	0.07	0.09
2026-10-15	TAK	0	0.07	0.09
2026-10-16	TAK	0	0.07	0.09
2026-10-19	TAK	0	0.22	0.09
2026-10-20	TAK	0	0.22	0.09
2026-10-21	TAK	0	0.22	0.09
2026-10-22	TAK	0	0.22	0
2026-10-23	TAK	0	0.22	0.09
2026-10-26	TAK	0	0.24	0.09
2026-10-27	TAK	0	0.24	0.10
2026-10-28	TAK	0	0.24	0.10
2026-10-29	TAK	0	0.24	0.10
2026-10-30	TAK	0	0.24	0.10
2026-11-02	TAK	0	0.14	0.10
2026-11-03	TAK	0	0.14	0.10
2026-11-05	TAK	0	0.14	0.10
2026-11-06	TAK	0	0.14	0.10
2026-11-09	TAK	0	0.07	0.10
2026-11-10	TAK	0	0.07	0.10
2026-11-11	TAK	0	0.07	0.10
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.51

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

0.07

Beta

Average Sales Estimate Current Quarter

7793

Average Sales Estimate Next Quarter

7184

Fair Value

23.48

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-23.3

Target Price

21.26

P/E

339.19

Forward P/E

31.25

PEG

1.12

P/S

2.23

P/B

1.41

P/Free Cash Flow

18.54

EPS

0.06

Average EPS Est. Cur. Y

148.67

EPS Next Y. (Est.)

198.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

0.81

Relative Volume

0.75

Return on Equity vs Sector %

-25.8

Return on Equity vs Industry %

-6.2

EPS 1 7Days Diff

-6.3

EPS 1 30Days Diff

-1.32

EBIT Estimation

2310

◆ TAK Healthcare

$20.86

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

9/15

Valuation

9/20

TP/AR

3/10

Options

7/10

RSI

63.9

Range 1M

71.5%

Sup Dist

0.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

18/30

Estimates

6/20

Inst/Vol

5/15

Options

8/10

EPS Yr

9.1%

EPS NY

59%

52W%

88.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +16617.8% upside

Quality

7/30

Valuation

20/30

Growth

14/25

Stability

3/10

LT Trend

1/5

Upside

+16617.8%

Quality

MoS

13%

TAK — P/E HistoricalDrug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company L

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 47029

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.

TAK

Latest News

—

Caricamento notizie per TAK…

stock quote shares TAK – Takeda Pharmaceutical Company Limited Stock Price stock today

news today TAK – Takeda Pharmaceutical Company Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch TAK – Takeda Pharmaceutical Company Limited yahoo finance google finance

stock history TAK – Takeda Pharmaceutical Company Limited invest stock market

stock prices TAK premarket after hours

ticker TAK fair value insiders trading

TAK – Takeda Pharmaceutical Company Limited

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: TAK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y